Q1 FY27 · Ended Sep 30, 2026 · View SEC filing
Overhead stood still, so profit grew far faster than sales
Selling and administrative costs rose 4.7% while sales rose 33.3%, so most extra gross profit reached pre-tax earnings.
For investorsWhat Clorox's earnings depend on as the easy comparisons end
For foundersBuying a channel instead of building one
Gross margin fell even as volume rose 31%, and sits well below the 45.8% of two years earlier.
Health and Wellness gained 8.65 points of share, pulling Clorox toward professional buyers that run on business-to-business terms.
Sales of $1,905M compare with $1,762M two years earlier, a far smaller gain than the headline rise suggests.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes Clorox from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
